The MM-GB/SA scoring technique has become an important computational approach in drug design. We, and others, have demonstrated that for congeneric molecules the correlation with experimental data obtained with the physics-based scoring is usually superior to scoring functions from typical docking algorithms. Despite showing good accuracy when applied within a series, much work is necessary to improve the MM-GB/SA method in order to gain greater efficiency in drug design. Here, we investigate the poor estimation of protein desolvation provided by the GB/SA solvation model and the large dynamic range observed in the MM-GB/SA scoring compared to that of the experimental data. In the former, replacing the GB/SA protein desolvation in the MM-GB/SA method by the free energy associated with displacing binding site waters upon ligand binding estimated by WaterMap provides the best results when ranking congeneric series of factor Xa and cyclin-dependent kinase 2 (CDK2) inhibitors. However, the improvement is modest over results obtained with the MM-GB/SA and WaterMap methods individually, apparently due to the high correlation between the free energy liberation of the displaced solvent and the protein-ligand van der Waals interactions, which in turn may be interpretable as estimates of the hydrophobic effect and hydrophobic-like interactions, respectively. As for the large dynamic range, comparisons between MM-GB/SA and FEP calculations indicate that for the factor Xa test set this problem has its origin in the lack of shielding effects of protein--ligand electrostatic interactions; that overly favors ligands that engage in hydrogen bonds with the protein.
No takes yet. Share an insight, caveat, or question.
Guimarães et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: